Peptides for Wound Healing & Tissue Repair

BPC-157 and TB-500 are the most commonly discussed wound healing peptides, with BPC-157 having broader preclinical evidence. GHK-Cu offers topical application advantages for surface wounds, while LL-37 adds antimicrobial protection particularly relevant for infected or at-risk wounds.

Wound healing peptides represent a promising area of research, with multiple compounds demonstrating potential to accelerate repair through complementary mechanisms. BPC-157, TB-500, GHK-Cu, and LL-37 each target different aspects of the healing cascade, from initial antimicrobial defence through to final tissue remodelling.

However, it is crucial to emphasise that none of these research peptides are approved wound healing treatments. Proper wound care—including cleaning, appropriate dressings, infection prevention, and medical assessment—remains the cornerstone of wound management.

For those interested in the science, this field continues to evolve with increasing understanding of how peptides interact with wound healing biology. Future clinical trials may eventually validate some of these preclinical findings for human therapeutic use.

*Always consult accredited suppliers and qualified healthcare professionals in your jurisdiction.*